Your English writing platform
Discover LudwigSuggestions(1)
Exact(2)
The aim of this study was to investigate if the levels of MMPs in blood samples are potential markers of early nephropathy in type 1 diabetes.
In addition, amyloid- β 1-42 peptide (A β-42), total tau (t-tau), and tau phosphorylated at the threonine 181 (p-tau181p), measured in CSF samples, are potential diagnostic biomarkers for AD [ 31– 31].
Similar(58)
PL studies demonstrated that the present samples were potential for the fabrication of white component of white light emitting diodes (WLEDs).
However, the comparative illusion detection rate in the AMT sample is potential cause for concern: The AMT sample appears to require 50 additional participants to reach detectability rates that are comparable to the laboratory sample.
Multiple testing, population stratification, genotyping errors, and initial small sample size are potential reasons for false-positive findings in the original study.
In fact, the collection, handling, storage, and analysis of blood samples are all potential sources of error.
Based on this criterion, only 0.8% of the sampled colonies were potential mosaics (i.e., 1 colony out of 124).
Although the recording of lesions is abattoir based, so only pigs of slaughter age are included in the sample, there is potential for BPHS data to support disease surveillance in pigs at a national level.
In addition, a drawback of conducting statistical analyses on studies with large sample sizes is potential for analyses to be statistically over-powered and hence an increased risk of making a Type I error.
Applications in clinical samples are discussed, and potential future directions are identified.
Once samples are collected, another potential source of error arises from the interpretation of histology.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com